Dr. Yau Chun Chung - Clinical Oncology
Highlights
- MCHK RegisteredVerified
- 1 LocationsJardine's Lookout
- Specialist in Clinical OncologyBachelor of Medicine and Bachelor of Surgery (MBBS) · Member of the Royal Colleges of Physicians of the United Kingdom · Fellow of the Royal College of Radiologists · Medical degree 1985
- InsuranceBeing compiled|See details
About
Dr. Yau Chun Chung practises Clinical Oncology in Jardine's Lookout, Hong Kong.
Education
- Bachelor of Medicine and Bachelor of Surgery (MBBS)Bachelor of Medicine and Bachelor of Surgery (MBBS)1985
- Member of the Royal Colleges of Physicians of the United KingdomMember of the Royal Colleges of Physicians of the United Kingdom
- Fellow of the Royal College of RadiologistsFellow of the Royal College of Radiologists
- Fellow of the Royal College of Physicians of EdinburghFellow of the Royal College of Physicians of Edinburgh
- FHKCRFellow, Hong Kong College of Radiologists
Source: Hong Kong Academy of Medicine Fellows Register, checked 12 Sep 2026
Locations
2 Village Road, Happy Valley, Hong Kong
Get Directions →Jardine's Lookout
Insurance
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Yau Chun Chung? Claim page and update insurance →
FAQ
Research and publications
12 papers
Filter by paper topic
Topics come from medical classifications on these PubMed papers, not from the doctor's listed services.
- Pre-operative radiotherapy for breast cancer patients receiving mastectomy and immediate autologous tissue reconstruction.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology · 2025
- Reply to: Comment on "Pre-operative radiotherapy for breast cancer patients receiving mastectomy and immediate autologous tissue reconstruction".European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology · 2025
- Epigenomic landscape study reveals molecular subtypes and EBV-associated regulatory epigenome reprogramming in nasopharyngeal carcinoma.EBioMedicine · 2022
- Clinical utility of serial analysis of circulating tumour cells for detection of minimal residual disease of metastatic nasopharyngeal carcinoma.British journal of cancer · 2020
- MicroRNA profiling study reveals miR-150 in association with metastasis in nasopharyngeal carcinoma.Scientific reports · 2017
- Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma.Proceedings of the National Academy of Sciences of the United States of America · 2016
- Whole-exome sequencing identifies MST1R as a genetic susceptibility gene in nasopharyngeal carcinoma.Proceedings of the National Academy of Sciences of the United States of America · 2016
- Metastasis-suppressing NID2, an epigenetically-silenced gene, in the pathogenesis of nasopharyngeal carcinoma and esophageal squamous cell carcinoma.Oncotarget · 2016
- IKBB tumor suppressive role in nasopharyngeal carcinoma via NF-κB-mediated signalling.International journal of cancer · 2016
- Comparative methylome analysis in solid tumors reveals aberrant methylation at chromosome 6p in nasopharyngeal carcinoma.Cancer medicine · 2015
- NF-κB p65 Subunit Is Modulated by Latent Transforming Growth Factor-β Binding Protein 2 (LTBP2) in Nasopharyngeal Carcinoma HONE1 and HK1 Cells.PloS one · 2015
- Risk factors and natural history of breast cancer in younger Chinese women.World journal of clinical oncology · 2014
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
Elsewhere on the web
Hospital pages
These links are matched automatically by the doctor's name and are not confirmed by the doctor. Names repeat in Hong Kong — open a link to check.
For reference only. Not medical advice. Read full disclaimer